Plain-English translation of NCT05095714 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding a special type of MRI scan (called fast-MRI) to regular ultrasound screening can help catch liver cancer earlier in people at high risk. Half of the participants will receive both ultrasound and fast-MRI scans every six months, while the other half will receive only ultrasound scans. Researchers want to see if the combination approach finds more early-stage cancers and whether it's worth the extra cost.
Many patients with cirrhosis or chronic liver disease are at high risk of developing liver cancer, but current screening with ultrasound alone may miss some early cancers. This trial is testing whether adding fast-MRI scans can improve the chances of finding cancer when it's still small and easier to treat.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will have visits every six months for three years. One group will receive both an ultrasound and an MRI scan at each visit, while the other group will receive only an ultrasound. If either scan finds a nodule or suspicious area, you'll have additional imaging or a biopsy to confirm whether it is cancer. The study will also track your quality of life and the costs involved in each screening approach.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
France